NCT05693207

Brief Summary

The main goal of this study is to evaluate, via EMG (electromyography) system, the muscle activity in the lower limbs, to understand the contribution of the muscle activity to FOG (freezing of gait) in Parkinson's patients. The phenomenon of FOG appears in advanced cases of Parkinson's disease (PD) and can lead to an increased risk of falls. There are several approaches claiming that there is abnormal activity in the calf muscles and the freezing events in Parkinson's patients. In the clinic, monitoring FOG is done subjectively, usually through observations or through questionnaires. As a result, the information about the phenomenon may be biased and insensitive. With an electromyographic monitor (EMG), objective information about the muscular activity during normal walking and during unusual events can be obtained.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 7, 2021

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

December 27, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

January 20, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 23, 2023

Completed
Last Updated

January 20, 2023

Status Verified

November 1, 2022

Enrollment Period

1.6 years

First QC Date

December 27, 2022

Last Update Submit

January 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage time of co-contractions

    The time of co-contraction during walking will be higher among people with FOG.

    60 minutes

Study Arms (2)

People with iPD with freezing of gait

EXPERIMENTAL
Device: EMG

People with iPD without freezing of gait

OTHER

control group

Device: EMG

Interventions

EMGDEVICE

wearables EMG

Also known as: Accelerometers and gyroscopes
People with iPD with freezing of gaitPeople with iPD without freezing of gait

Eligibility Criteria

Age40 Years - 89 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women aged 40-89.
  • Patients with idiopathic Parkinson's disease according to the diagnosis of a neurologist, who are able to walk with or without a walking aid for at least 5 minutes.
  • or above in MoCA test.
  • people who gave their written and oral consent to participate in the study.
  • Men and women aged 40-89.
  • or above in MoCA test.
  • Without a neurological, cardiovascular or orthopedic disorder, which could affect the normal walking pattern, and all within the researcher's decision.
  • The patient has serious side effects that are not suitable for continuing in the study.
  • The patient does not wish to continue his participation in the study.

You may not qualify if:

  • Neurological or other psychiatric disorder (such as MSA, PSP, after a stroke with neurological signs, dementia diseases, clinical depression) at the researcher's decision.
  • History of head injury - traumatic brain injury or cerebrovascular accident (CVA)
  • This study will not include pregnant women and children.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tel aviv medical center

Tel Aviv, Israel

RECRUITING

Related Publications (6)

  • Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014 Nov;29(13):1583-90. doi: 10.1002/mds.25945. Epub 2014 Jun 28.

    PMID: 24976103BACKGROUND
  • Bloem BR, Hausdorff JM, Visser JE, Giladi N. Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord. 2004 Aug;19(8):871-84. doi: 10.1002/mds.20115.

    PMID: 15300651BACKGROUND
  • Silva de Lima AL, Evers LJW, Hahn T, Bataille L, Hamilton JL, Little MA, Okuma Y, Bloem BR, Faber MJ. Freezing of gait and fall detection in Parkinson's disease using wearable sensors: a systematic review. J Neurol. 2017 Aug;264(8):1642-1654. doi: 10.1007/s00415-017-8424-0. Epub 2017 Mar 1.

    PMID: 28251357BACKGROUND
  • Hanein Y, Mirelman A. The Home-Based Sleep Laboratory. J Parkinsons Dis. 2021;11(s1):S71-S76. doi: 10.3233/JPD-202412.

    PMID: 33682729BACKGROUND
  • Inzelberg L, David-Pur M, Gur E, Hanein Y. Multi-channel electromyography-based mapping of spontaneous smiles. J Neural Eng. 2020 Apr 9;17(2):026025. doi: 10.1088/1741-2552/ab7c18.

    PMID: 32271717BACKGROUND
  • Mazzetta I, Zampogna A, Suppa A, Gumiero A, Pessione M, Irrera F. Wearable Sensors System for an Improved Analysis of Freezing of Gait in Parkinson's Disease Using Electromyography and Inertial Signals. Sensors (Basel). 2019 Feb 23;19(4):948. doi: 10.3390/s19040948.

    PMID: 30813411BACKGROUND

Study Officials

  • Nir Giladi, Prof

    Study Principal Investigator Tel-Aviv Sourasky Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jeffrey Hausdorff, Phd

CONTACT

David Buzaglo, B.pt

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 27, 2022

First Posted

January 20, 2023

Study Start

October 7, 2021

Primary Completion

May 23, 2023

Study Completion

December 23, 2023

Last Updated

January 20, 2023

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations